Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05657938 · ClinicalTrials.gov registry record
Evaluation of Home Based Assessments on Participants With DMD
A clinical trial, sponsored by Solid Biosciences.
- Completed
- Registry status
- 17
- Enrollment target
NCT05657938: Completed study, sponsored by Solid Biosciences.
NCT05657938 is a clinical trial that has completed, run by Solid Biosciences. The registered enrollment target is 17 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05657938 has completed, sponsored by Solid Biosciences.
- COMPLETED
- Registry status
- 17 participants
- Enrollment target
Study Summary
This study is designed to evaluate the feasibility, wearability and participant satisfaction of novel outcome assessment tools in DMD patients which are performed in the home environment.
Primary Outcome
The wearable sensor device is composed of three small sticker-based sensors that are worn on the chest, thigh and ankle to record activity. Participants will wear the sensors during specified periods over the study duration and compliance will be assessed based on recorded activity.
Interventions
- DEVICE Wearable Device
- OTHER Duchenne Video Assessment (DVA)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2022-10-13 |
| Est. Completion | 2023-04-04 |
What the finished NCT05657938 record still lists
NCT05657938 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 17 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Wearable Device is the first listed.
NCT05657938 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05657938 about?
NCT05657938 is a clinical study titled "Evaluation of Home Based Assessments on Participants With DMD". This study is designed to evaluate the feasibility, wearability and participant satisfaction of novel outcome assessment tools in DMD patients which are performed in the home environment.
What is the current status of trial NCT05657938?
This trial is currently completed. The enrollment target is 17 participants. The study started on 2022-10-13. Estimated completion is 2023-04-04.
What interventions are being tested in trial NCT05657938?
The interventions under investigation include: Wearable Device (DEVICE), Duchenne Video Assessment (DVA) (OTHER).
Who is sponsoring clinical trial NCT05657938?
This trial is sponsored by Solid Biosciences, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI